AKR1C3-IN-9, a selective Aldo-keto Reductase 1C3 (AKR1C3) inhibitor (IC50 = 8.92 nM), can significantly reverse Doxorubicin (DOX) resistance in a resistant breast cancer cell line.
Molecular Weight:
352.38
Purity:
99.41%
Formula:
C20H20N2O4
Target:
Reductase|||NADPH
T67846
* VAT and and shipping costs not included. Errors and price changes excepted